Announcement of Rogocekib Dose-Escalation Cohort Data Presentation at the 2026 European Hematology Association (EHA)
Chordia Therapeutics has announced data from the Phase 1/2 trial (CTX-712-CL-02) of rogocekib (CTX-7… · 2026-06-15
Chordia Therapeutics has announced data from the Phase 1/2 trial (CTX-712-CL-02) of rogocekib (CTX-7… · 2026-06-15
Chordia Therapeutics has released an explanatory video and supplementary materials to enhance unders… · 2026-06-15